Company Filing History:
Years Active: 2011-2021
Title: Joaquim Trias: Innovator in Biochemical Applications
Introduction
Joaquim Trias is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of innovative compounds and methods for medical applications. With a total of 2 patents, his work focuses on enhancing the delivery of biologically active molecules and addressing cardiovascular diseases.
Latest Patents
One of Joaquim Trias's latest patents is centered around Polyethylenimine (PEI)-polypeptide conjugates and methods of use thereof. This application provides PEI compounds that include a linker and PEI-polypeptide conjugates, such as PEI-antibody conjugates. The invention also details methods for preparing and utilizing these compounds, which are instrumental in delivering biologically active molecules to the cytoplasm of cells. Additionally, it promotes the release of these molecules from the endo-lysosomal pathway. Another significant patent involves the administration of sPLA inhibitors, which have been shown to decrease cholesterol levels and atherosclerotic plaque formation in mice, as well as lower cholesterol and triglyceride levels in humans. This patent outlines methods for treating dyslipidemia and cardiovascular diseases (CVD) through the administration of sPLA inhibitors, either alone or in combination with other compounds like statins.
Career Highlights
Throughout his career, Joaquim Trias has worked with various companies, including Apg Therapeutics, Inc. and Anthera Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of biochemistry.
Collaborations
Joaquim has collaborated with notable individuals in his field, including Jaume Pons and David L Shelton. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Joaquim Trias is a distinguished inventor whose work in biochemistry has led to significant advancements in medical applications. His patents reflect a commitment to improving health outcomes through innovative solutions.